U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 18 results

Status:
US Approved Rx (2011)
First approved in 2011

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Vandetanib, 4-anilinoquinazoline, is an anti-cancer drug that with the potential for use in a broad range of tumour types. In 2011 vandetanib (trade name Caprelsa) was approved by the FDA to treat nonresectable, locally advanced, or metastatic medull...
mixture
Status:
Possibly Marketed Outside US
First approved in 2013

Class:
MIXTURE

Status:
Investigational

Class:
PROTEIN

Status:
Investigational

Class:
PROTEIN

Showing 1 - 10 of 18 results